Medicaments to combat autoimmune diseases, in particular systemi

Details Medicaments to combat autoimmune diseases, in particular systemi Medicaments to combat autoimmune diseases, in particular systemi

1992-04-17

1993-12-07

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514521, A61K 3142, A61K 31275

Patent

active

052683826

ABSTRACT:
A pharmaceutical composition for use in the treatment of chronic Graft-versus-host diseases as well as autoimmune diseases, in particular for the treatment of systemic lupus erythematosus containing as an active ingredient at least one compound of the formulae 1 or 2 ##STR1## the latter being present per se or in the form of a physiologically tolerable salt.
The invention also relates to a dosage unit form of said pharmaceutical composition and a method of treating chronic Graft-versus-host diseases as well as autoimmune diseases, in particular systemic lupus erythematosus.

REFERENCES:
patent: 4284786 (1981-08-01), Kammerer et al.
patent: 4435387 (1984-03-01), Schaub et al.
patent: 4435407 (1984-03-01), Wacker
patent: 4965276 (1990-10-01), Bartlett et al.
Burling Amer Drug Int. Clin. Phar., 1988/22, 283-289.
Oxford Textbook of Medicine, Second Edition, eds. D. J. Weatherall, J. G. G. Ledingham and D. A. Warrell, vol. 2, pp. 16.20-16.28 and 21.211-21.216 (1987).

Affiliated with

Also associated with

Rating

Medicaments to combat autoimmune diseases, in particular systemi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicaments to combat autoimmune diseases, in particular systemi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments to combat autoimmune diseases, in particular systemi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2015993